IT1254544B - New L-verbenone derivative and pharmaceutical compositions containing it - Google Patents
New L-verbenone derivative and pharmaceutical compositions containing itInfo
- Publication number
- IT1254544B IT1254544B ITMI920660A ITMI920660A IT1254544B IT 1254544 B IT1254544 B IT 1254544B IT MI920660 A ITMI920660 A IT MI920660A IT MI920660 A ITMI920660 A IT MI920660A IT 1254544 B IT1254544 B IT 1254544B
- Authority
- IT
- Italy
- Prior art keywords
- verbenone
- new
- pharmaceutical compositions
- compositions containing
- verbenone derivative
- Prior art date
Links
- DCSCXTJOXBUFGB-JGVFFNPUSA-N (S)-(-)-verbenone Chemical class CC1=CC(=O)[C@@H]2C(C)(C)[C@H]1C2 DCSCXTJOXBUFGB-JGVFFNPUSA-N 0.000 title abstract 4
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 230000000694 effects Effects 0.000 abstract 2
- 229920000858 Cyclodextrin Polymers 0.000 abstract 1
- 239000001116 FEMA 4028 Substances 0.000 abstract 1
- 230000002411 adverse Effects 0.000 abstract 1
- WHGYBXFWUBPSRW-FOUAGVGXSA-N beta-cyclodextrin Chemical compound OC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1CO WHGYBXFWUBPSRW-FOUAGVGXSA-N 0.000 abstract 1
- 235000011175 beta-cyclodextrine Nutrition 0.000 abstract 1
- 229960004853 betadex Drugs 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 230000000241 respiratory effect Effects 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
Landscapes
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
The complex of L-verbenone with Beta-cyclodextrin of formula I: <IMAGE> has therapeutic properties deriving from the intrinsic activity of the L-verbenone on diseases of the respiratory apparatus while having less adverse effects than L-verbenone itself.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ITMI920660A IT1254544B (en) | 1992-03-23 | 1992-03-23 | New L-verbenone derivative and pharmaceutical compositions containing it |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ITMI920660A IT1254544B (en) | 1992-03-23 | 1992-03-23 | New L-verbenone derivative and pharmaceutical compositions containing it |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| ITMI920660A0 ITMI920660A0 (en) | 1992-03-23 |
| ITMI920660A1 ITMI920660A1 (en) | 1993-09-23 |
| IT1254544B true IT1254544B (en) | 1995-09-25 |
Family
ID=11362532
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ITMI920660A IT1254544B (en) | 1992-03-23 | 1992-03-23 | New L-verbenone derivative and pharmaceutical compositions containing it |
Country Status (1)
| Country | Link |
|---|---|
| IT (1) | IT1254544B (en) |
-
1992
- 1992-03-23 IT ITMI920660A patent/IT1254544B/en active IP Right Grant
Also Published As
| Publication number | Publication date |
|---|---|
| ITMI920660A1 (en) | 1993-09-23 |
| ITMI920660A0 (en) | 1992-03-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL112029A (en) | Raloxifine and related compounds for use as medicaments for the treatment of disorders associated with an excess of tachykinin | |
| NZ247201A (en) | Substituted sulphonylamido- or sulphonamidocarbonyl-pyridine-2-carboxamide derivatives and pharmaceutical compositions | |
| NO902800L (en) | PROCEDURE FOR THE PREPARATION OF 11BETA-ARYL-4-OESTERS. | |
| GR3006815T3 (en) | ||
| DE3480053D1 (en) | A kit or device and method for administering gangliosides and derivatives thereof of inhalation and pharmaceutical compositions suitable therefor | |
| AU1430492A (en) | Pharmaceutical composition for the treatment of gastritis | |
| ATE170075T1 (en) | ANTIVIRAL MEDICINAL PRODUCT CONTAINING PROSTRATIN | |
| IL101245A0 (en) | Pharmaceutical compositions for the treatment of prostatic cancer | |
| AU9173191A (en) | Medicaments for the treatment of papillomavirus diseases | |
| AU2806692A (en) | Medicament for the treatment of anxiety | |
| CA2135709A1 (en) | Melatonin derivatives for use in treating sleep disorders | |
| IL105475A (en) | PHARMACEUTICAL COMPOSITIONS CONTAINING 1a, 24(R) - DIHYDROXY-22(E)-DEHYDRO- VITAMIN D3 FOR TREATING OSTEOPOROSIS | |
| PH30702A (en) | Method of treating colon disturbances with pharmaceutical compositions containing imidazol-1yl-compounds. | |
| AU7812794A (en) | Pharmaceutical compositions containing n-acetylcarnosine for the treatment of cataract | |
| ZA929879B (en) | Compositions for the treatment of mammalian diseases. | |
| IT1254544B (en) | New L-verbenone derivative and pharmaceutical compositions containing it | |
| EP0314984A3 (en) | Use of 2-pyrimidinyl-1-piperazine derivatives | |
| TW330933B (en) | Furanoeremophilane and eremophilanolide sesquiterpenes for treatment of diabetes | |
| AU8505991A (en) | Use of compositions containing 2-(6'-substituted-2'-naphthyl)-acetic acid derivatives for the treatment of respiratory disorders | |
| IL106751A0 (en) | Pharmaceutical compositions for the treatment of reversible obstructive airways diseases | |
| IL109235A0 (en) | Pharmaceutical compositions containing ureido derivatives for the treatment of lentivirus-induced diseases | |
| IL99666A0 (en) | Pharmaceutical compositions for the treatment of diabetes | |
| AU658197B2 (en) | New use of benzimidazoline-2-oxo-1-carboxylic acid derivatives | |
| IL111138A (en) | Pharmaceutical compositions comprising penciclovir and/or its bioprecursor and/or its derivatives for the treatment and prophylaxis of post-herpetic neuralgia | |
| IL98199A (en) | Pharmaceutical compositions containing a derivative of substituted l-valyl-l-prolinamide |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 0001 | Granted | ||
| TA | Fee payment date (situation as of event date), data collected since 19931001 |
Effective date: 19950327 |